# FDA Inspection 1050332 - Biomat USA, Inc - April 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cd3bf4cb-3357-4833-9d24-9c05f472d17f
Source feed: FDA_Inspections

> FDA Inspection 1050332 for Biomat USA, Inc on April 25, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050332
- Company Name: Biomat USA, Inc
- Inspection Date: 2018-04-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 975837 - 2016-06-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8c945455-c2c4-45d4-8715-d4cfd581a9fc)

Company: https://www.keypedia.com/companies/biomat-usa-inc/7c07a390-fb8e-4f92-b7fe-4b55b71ae02f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d